Navigating the Science: An Evidence Based Methodology to Bridge the Gap Between Clinical and Environmental Health Sciences Tracey J Woodruff, PhD, MPH.

Slides:



Advertisements
Similar presentations
Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Advertisements

Engaging Patients and Other Stakeholders in Clinical Research
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
Plenary I Preview of Public Health Action Plan to Prevent Heart Disease and Stroke – 2013 Update: Overview and Discussion.
The Cochrane Library University Library.
UPenn Prevention Research Center’s CPCRN Collaborating Center University of Pennsylvania (UPenn) Prevention Research Center is a new PRC, Principal.
National Institute for Public Health and the Environment Bilthoven, The Netherlands National Vaccin Institute.
Program Science Initiative Updates, Goals and Directions James Blanchard, MD, MPH, PhD Professor and Director, Centre for Global Public Health University.
Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.
Driving patient safety National Standard Demographic Dataset for use in health and social care settings in Ireland Barbara Foley, PhD Tracy O’Carroll Health.
AHRQ’s Role in Comparative Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality Alliance for Health Reform Briefing.
Evidence based implementation for quality and health promotion in hospitals Professor Jos Kleijnen Director Centre for Reviews and Dissemination University.
Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of.
Connecting Communities for Better Health PHDSC / eHealth Initiative Annual Conference Accelerating the Development of Health Information Exchanges and.
Biomedical Research. What is Biomedical Research Biomedical research is the area of science devoted to the study of the processes of life; prevention.
1 Translating scientific knowledge for policy and stakeholder audiences Amy D. Kyle, PhD MPH Martyn T. Smith, PhD Superfund Basic Research Program Research.
Paul RobbenDutch Health Care Inspectorate Research & Innovation Department Evaluation of supervision and the Academic Collaborative Centre.
Advancing Excellence in Health Care Perinatal Depression: Prevalence, Screening, Accuracy and Screening Outcomes Susan F. Meikle, M.D., M.S.P.H. Senior.
ROLE DEVELOPMENT Director of Acute Care Advanced Practice Providers (DACAPP) Vagn Petersen, MS, ACNP-BC Interim Lead NP Surgical Services – SFGH & Trauma.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Dr. J. Tack – Belgian Biodiversity Platform Belgian global change research Assessment and Integration Report Dr. J. Tack Belgian Biodiversity.
The program is to build the creativity, critical ability, and lifelong learning ability in students. (International Program) Train students to conducts.
A 2 DAHT provides evidence-based, unbiased, reliable and trusted health technology assessments and Education for a better global healthcare. Our results.
Essential Resources for the Infection Preventionist Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville.
Medicaid and the Effective Health Care Program William Lawrence, MD, MS Center for Outcomes and Evidence.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
David M. Deci, M.D. Director Office of Medical Student Education Associate Professor, Department of Family Medicine University of Wisconsin School of Medicine.
Program on Reproductive Health and the Environment Moving into the Future: New Science and Decision Making Tracey J Woodruff, PhD, MPH Associate Professor,
Department of Human Services Evaluating Effectiveness of Participation Projects Learning Session Why evaluate the effectiveness of consumer, care and community.
ETHICAL APPLICATIONS OF INFORMATICS ANN LAVERN L. FERRAZ, RN.
Training Name: CLINICAL PHARMACY FROM BOOKS TO IMPLEMENTATION Module1: 1. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management.
Clinical Quality Improvement: Achieving BP Control
Developing a Research Question
Review of all hazard disaster databases sub-committee
Approach to guideline development
Healthy Pregnancies Healthy Children Healthy Future Generations
Efficacy and Safety of Medicines
Developing a guideline
Viral Suppression at the First Integrated Methadone and Antiretroviral Therapy Program for People who Inject Drugs in sub-Saharan Africa Dar es Salaam,
Patient Focused Drug Development An FDA Perspective
PHARMACIST : A HEALTH CARE PROFESSIONAL
US Preventive Services Task Force :
Children First: Promoting Ecological Health for the Whole Child
Evidence-Based Practice I: Definition – What is it?
METHODS RECOMMENDATIONS BACKGROUND
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
METHODS RECOMMENDATIONS BACKGROUND
Reporting Approaches and Best Practices Jennifer Benjamin NCQA
The new Professional Leadership Body: supporting advanced and specialist practice Dr Catherine Duggan.
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
Donna Petersen, ScD, MHS, CPH
Workforce Planning Framework
Jason Gerson, PhD Clinical Effectiveness and Decision Science
Tackling Musculoskeletal Problems
Leading professional association for infection preventionists (IPs)
AccessPediatrics from McGraw-Hill is an authoritative online resource of pediatric information for today’s: Residents Instructors Students Clinicians.
Navigating the Science: evaluating the research quality
Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary  Tracey J. Woodruff, Ph.D., M.P.H., Alison.
Policy Change Department of Veterans Affairs
WAFCC Standards of Excellence – baseline survey results
What Should a Mission Do?
Raising the bar Meeting Europe’s future challenges
Health Technology Assessment in India
Office of Environmental Health Hazard Assessment Overview & Updates
An introduction to EMA’s support for medicines development
The Components of Evidence-Based Practice (EBP)
Process mapping of registration to reimbursement for new pharmaceuticals in UK Description: A systematic methodology was developed in order to create the.
Members Meeting Leadership Consortium for a Value & Science-Driven Health System March 21, 2019 Vision  Research  Evidence  Effectiveness  Trials.
University of Oklahoma Health Sciences Center
Humboldt Space Research Mission America. Humboldt Space Co. adopts a forward thinking stance in scientific research and technical development. Our policy.
Presentation transcript:

Navigating the Science: An Evidence Based Methodology to Bridge the Gap Between Clinical and Environmental Health Sciences Tracey J Woodruff, PhD, MPH Associate Professor, Director Program on Reproductive Health and the Environment University of California, San Francisco

What’s A Healthcare Decision-Maker To Do? The scientific evidence is voluminous, of variable quality and largely unfamiliar to health professionals caring for women and men of childbearing age There is no trusted, ready reference or compendium that provides healthcare decision-makers with timely, evidence-based advice about exposure to environmental contaminants 2 2

What’s A Healthcare Decision-Maker To Do? There is a need for timely incorporation of the science into recommendations for prevention on national, community and individual levels 3 3

But Evidence Based Medicine Methodologies Are Not Directly Transferable to Environmental Science! 4 4

Evidence Stream Differences 5 5

Decision-Context Differences In general, Pharmaceuticals must show efficacy and safety prior to exposing humans Manufactured chemicals need to show evidence of harm prior to removing human exposure

Navigation Guide Authored by 22 scientist and clinician collaborators from US and Europe

Navigation Guide Systematic and transparent methodology Provides uniform, simple, and transparent summaries that integrates the best practices of evaluation in environmental and clinical health sciences

Program on Reproductive Health and the Environment Jackie Schwartz Jason Harless Ami Zota Tracey Woodruff (director) Patrice Sutton Joanne Perron Carrie Dickenson Linda Giudice (chair Ob/Gyn and founder) Mission To create a healthier environment for human reproduction and development by advancing scientific inquiry, clinical care, and health policies that prevent exposures to harmful chemicals in our environment